Modag

Focus: Modag is a German diagnostics and therapeutics company focused on neurodegenerative diseases, particularly Parkinson's disease. The company operates at an early clinical stage with limited public visibility.

Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Modag

AI assessmentNot Hiring

No open roles listed right now. Follow Modag to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

3 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

anle138b

Parkinson Disease

Phase 1

Clinical Trials (1)

NCT04685265A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of anle138b in Parkinson's Disease

Phase 1

Help build intelligence for Modag

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focus on high-unmet-need neurodegenerative space positions you in a clinically meaningful area with significant upside potential
Early-stage pipeline (Phase 1) offers ground-floor opportunity to shape development strategy and clinical programs
German headquarters in biotech-active region provides access to European talent and regulatory expertise

Watch Out For

No active job postings (0 openings) indicates company is either in stealth mode, early scaling phase, or facing hiring freeze
Extremely early-stage pipeline (only Phase 1 data on single asset anle138b) means many years until potential commercial validation or revenue inflection
No disclosed financials, funding, or employee count raises transparency concerns and makes stability assessment impossible

Generated by Claude from Modag's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

anle138b

Healthy Volunteers

Phase 1

anle138b

Healthy Volunteers

Phase 1

Clinical Trials (1)

NCT04208152A First-in-Human Study of Single and Multiple Doses of anle138b in Healthy Subjects

Phase 1